• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Gendex buy adds to Del's sales growth

Article

Del Global Technologies of Valhalla, NY, reported strong growthin both revenues and earnings for fiscal 1996, thanks to a combinationof internal revenue growth and the addition of sales from x-rayvendor Gendex, which Del bought earlier this year (SCAN

Del Global Technologies of Valhalla, NY, reported strong growthin both revenues and earnings for fiscal 1996, thanks to a combinationof internal revenue growth and the addition of sales from x-rayvendor Gendex, which Del bought earlier this year (SCAN 12/27/95).

For the year (end-August), Del reported net sales of $43.7million, a company record and a figure that is 35% higher thanthe $32.6 million in revenues reported in fiscal 1995. Net incomewas $2.9 million, compared with $1.9 million in the prior year.

Del's revenues grew at an even greater rate in the fourth quarter,as the Gendex operations began contributing revenue in the middleof Del's third quarter. Del's revenues jumped 45% to $14.4 million,compared with $9.9 million in the fourth quarter of 1995. Netincome for the period was $970,000, compared with $427,000 inthe fourth quarter of 1995.

Medical imaging sales now contribute 59% of Del's revenues,according to chief executive Leonard Trugman. Del saw growth insales of power conversion subsystems for medical imaging applications,and the company's backlog stood at $23 million at year end, Trugmansaid. The company is planning to display a new neonatal imagingsystem at next month's Radiological Society of North America meeting.

Recent Videos
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
Related Content
© 2024 MJH Life Sciences

All rights reserved.